About Us
Current Events
Past Events
Video Gallery
Policy & Reports
Media Coverage
Contact Us

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

As a service to the BioPharma community in these unprecedented times, USAIC is offering Free Registration for its annual summit.
Registration is closed. Thanks for your overwhelming response. See you at 2021 summit- June 22. Marriott Cambridge, Massachusetts, USA
15th Annual BioPharma & Healthcare Summit, Tuesday, June 22, 2021 - Virtual Meeting
Registration is closed
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!

Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals
Summit Theme: "From N of One to N of a Billion"

15th annual BioPharma & Healthcare Summit
Virtual Summit
Date: Tuesday, June 22, 2021
Time: 8 AM to 4:00 PM EST (Eastern Standard Time)

*Speaker and Timings subject to change
Time Topic
8:00 AM - 8:10 AM Welcome address: Karun Rishi, President, USAIC

Opening comments: Dr Andrew Plump, President of R&D, Takeda Pharmaceuticals
8:10 AM - 8:50 AM Fireside Chat

Dr. Albert Bourla, Chairman & CEO, Pfizer

Dr. Stelios Papadopoulos, Chairman of the Board, Biogen
8:50 AM - 8:55 AM Polling + Break
8:55 AM - 9:35 AM India Innovation Panel

Amitabh Kant, Chief Executive Officer, National Institution for Transforming India
Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited
Prof. K. Vijay Raghavan, Principal Scientific Advisor, Government of India
Dr. Naresh Trehan, Chairman, Medanta Hospital

Sanat Chattopadhyay, President- Merck Manufacturing Division, Merck & Co.
9:35 AM - 9:40 AM Polling + Break
9:40 AM - 10:20 AM Rare Disease Panel

Dr. David Meeker, Chairman & CEO, Rhythm Pharmaceuticals
Dr. Frank Bennett, Chief Scientific Officer, Ionis Pharmaceuticals
Dr. John Orloff, Head of Research & Development, Alexion
Dr. Katherine High, President - Therapeutics, AskBio
Majid Jafar, Co-Founder, Loulou Foundation

Dr. Alfred Sandrock, Head of Research and Development, Biogen
10:20 AM - 10:25 AM Polling + Break
10:25 AM - 10:55 AM Fireside Chat

Robert Bradway, Chairman & CEO, Amgen

Kiran Mazumdar-Shaw, Executive Chairperson, Biocon
10:55 AM - 11:00 AM Polling + Break
11:00 AM - 11:45 AM Fireside Chat

Dr. Francis Collins, Director, National Institutes of Health
Dr. Margaret Hamburg, Former Commissioner, U.S. Food and Drug Administration

Dr. Elias Zerhouni, Professor Emeritus, Johns Hopkins University
11:45 AM - 11:50 AM Polling + Break
11:50 AM - 12:30 PM Oncology Panel

Dr. Bruce Chabner, Director of Clinical Research, Massachusetts General Hospital Cancer Center
Dr. Carrie Brownstein, Chief Medical Officer, Cellectis
Dr. Philip Larsen, Global Head of Research, Bayer AG
Dr. Sam Waksal, Founder, MeiraGTx
Vivek Ramaswamy, Founder & Executive Chairman, Roivant Sciences

Dr. Alise Reicin, Chief Executive Officer, Tectonic Therapeutic
12:30 PM - 12:40 PM Polling + Break
12:40 PM - 1:20 PM Industry & Investment Outlook Panel

Christopher Viehbacher, Managing Partner, Gurnet Point Capital
Dr. Peter Orszag, Chief Executive Officer - Financial Advisory, Lazard Freres
Rajiv Kaul, Portfolio Manager, Fidelity Investments
Dr. Stelios Papadopoulos, Chairman, Biogen

Daphne Zohar, Co-Founder and Chief Executive Officer, PureTech Health
1:20 PM - 1:25 PM Polling + Break
1:25 PM - 2:10 PM Fireside Chat

Dr. Janet Woodcock, Acting Commissioner, U.S. Food and Drug Administration

Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School
2:10 PM - 2:15 PM Polling + Break
2:15 PM - 3:00 PM R&D Strategies & Trends Panel

Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals
Dr. David Reese, Executive Vice President, Research and Development, Amgen
Dr. John Reed, Global Head of R&D, Sanofi
Dr. Mathai Mammen, Global Head of Janssen R&D, Johnson & Johnson

Dr. Martin Mackay, Co-Founder, Rallybio
3:00 PM - 3:05 PM Polling + Break
3:05 PM - 3:45 PM Digital & Data Science Panel

Craig Kennedy, Senior Vice President, Merck & Co.
Dr. Daphne Koller, Founder & CEO, insitro
Dr. Karen Akinsanya, Chief Biomedical Scientist, Schrödinger
Dr. Najat Khan, Chief Data Science Officer, Janssen Research & Development
Dr. Robert Califf, Head of Clinical Policy & Strategy, Verily & Google Health

Sastry Chilukuri, President, Acorn AI- Medidata
3:45 PM - 4:00 PM Closing Remarks

Dr. Andrew Plump, President of Research & Development, Takeda Pharmaceuticals
Advisory Board Members
Pharmasia News BioCentury
© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Legal | Contact us